Cryoport, Inc. (CYRX)

Name: Cryoport, Inc. (CYRX) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001124524 · Nasdaq · Pharmaceutical Preparations

Sector Manufacturing
Incorporated NV
Fiscal year ends around Dec 31

For the year ended 2025-12-31, Cryoport, Inc. reported revenue of $176.18M. Revenue grew 12.4% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $186.45M.

Key ratios (year ended 2025-12-31)

47.1%

Gross margin

-20.9%

Operating margin

44.4%

Net margin

15.6%

Return on year-end equity

12.4%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-08-11

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$186.45M	$176.18M	$156.77M	$168.66M	$237.28M	$222.61M	$78.70M	$33.94M	$19.63M	$11.95M	$7.68M
Cost of Revenue	$98.68M	$93.12M	$87.11M	$93.33M	$133.40M	$126.03M	$42.36M	$16.59M	$9.39M	$5.99M	$4.58M
Gross Profit	$87.77M	$83.05M	$69.66M	$75.33M	$103.87M	$96.58M	$36.33M	$17.35M	$10.24M	$5.97M	$3.10M
R&D Expense	$17.75M	$17.04M	$17.71M	$18.04M	$15.72M	$16.84M	$9.48M	$3.74M	$1.84M	$1.21M	$598.1K
Operating Income	-$39.62M	-$36.81M	-$121.67M	-$100.54M	-$31.90M	-$17.83M	-$30.01M	-$17.68M	-$8.64M	-$7.89M	-$8.77M
Depreciation & Amortization	$25.76M	$27.71M	$30.76M	$27.49M	$22.77M	$20.25M	$9.87M	$2.42M	$857.9K	$664.8K	$374.2K
EBITDA	-$13.86M	-$9.09M	-$90.91M	-$73.05M	-$9.14M	$2.42M	-$20.14M	-$15.26M	-$7.79M	-$7.23M	-$8.39M
Net Income	n/a	$78.30M	-$114.76M	-$99.59M	-$37.33M	-$275.53M	-$32.69M	-$18.33M	-$9.56M	-$7.90M	-$13.11M
EPS (Diluted)	n/a	$1.40	-$2.49	-$2.21	-$0.93	-$6.18	-$1.94	-$0.55	n/a	n/a	n/a
Total Assets	$756.20M	$764.99M	$703.49M	$957.74M	$1.04B	$1.11B	$552.40M	$135.87M	$56.62M	$20.26M	$8.11M
Total Liabilities	$265.50M	$262.35M	$301.59M	$468.72M	$482.91M	$471.14M	$169.71M	$9.59M	$18.07M	$2.38M	$2.43M
Shareholders' Equity	$490.70M	$502.64M	$401.90M	$489.02M	$555.84M	$641.83M	$382.70M	$126.28M	$38.55M	$17.89M	$5.68M
Cash & Equivalents	$269.27M	$250.49M	$34.14M	$35.19M	$36.59M	$139.10M	$36.87M	$47.23M	$37.33M	$15.04M	$4.52M
Operating Cash Flow	$7.97M	-$8.58M	-$16.32M	-$757.0K	-$1.85M	$8.13M	-$14.87M	-$1.32M	-$3.35M	-$3.58M	-$5.72M
Capital Expenditures	$28.00M	$16.44M	$17.25M	$38.78M	$22.11M	$23.88M	$8.92M	$5.34M	$2.91M	$1.71M	$1.06M
Free Cash Flow	-$20.03M	-$25.02M	-$33.58M	-$39.54M	-$23.96M	-$15.76M	-$23.78M	-$6.66M	-$6.27M	-$5.30M	-$6.78M
Share Repurchases	n/a	$10.01M	n/a	n/a	$37.96M	$0	$0	n/a	n/a	n/a	n/a
Shares Outstanding	50.65M	49.85M	49.91M	48.97M	48.33M	49.62M	39.84M	37.34M	30.32M	25.70M	17.60M
Weighted Average Diluted Shares	n/a	50.07M	49.35M	48.74M	48.99M	45.93M	38.58M	33.39M	n/a	n/a	n/a
EPS (Basic)	n/a	$1.40	-$2.49	-$2.21	-$0.93	-$6.18	-$1.94	-$0.55	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView